Confirming Rumors, Novartis Buys AAA To Boost Oncology Business

 
• By Sten Stovall

Integrating AAA will add to Novartis' expertise in diseases associated with neuroendocrine tumors and bring it a new technology platform for treating cancer.

Acquisition
Novartis' Planned AAA Buy Targets First-In-Class Radiopharmaceuticals • Source: Shutterstock

More from Strategy

More from Business